End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.94 THB | +1.38% | +0.68% | -6.37% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The group's high margin levels account for strong profits.
- The company is in a robust financial situation considering its net cash and margin position.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- The opinion of analysts covering the stock has improved over the past four months.
Weaknesses
- The firm trades with high earnings multiples: 25.93 times its 2024 earnings per share.
- The company's enterprise value to sales, at 3.58 times its current sales, is high.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-6.37% | 878M | B | ||
+25.52% | 88.99B | C+ | ||
-24.52% | 74.82B | B- | ||
+0.49% | 25.03B | C+ | ||
+4.31% | 17.88B | A- | ||
-14.25% | 16.43B | B | ||
+2.97% | 15.77B | A- | ||
+79.20% | 13.21B | C+ | ||
+70.11% | 13.08B | C- | ||
+40.44% | 12.9B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CHG Stock
- Ratings Chularat Hospital